Optics Outfitter
Why this eyewear company’s advertised “starting” prices may not be 20/20.
November 2016: This action was voluntarily dismissed pursuant to a settlement agreement reached between the parties, the terms of which have not been disclosed.
September 2016: The parties in a class-action lawsuit filed against Patent Health, L.L.C. in 2013 for allegedly deceptively marketing Trigosamine glucosamine supplements, reached a settlement agreement. The plaintiffs had alleged that the company deceptively claimed the supplements provide a variety of health benefits – including relieving joint pain, lubricating joints, and building cartilage – without adequate scientific evidence to support such claims. The terms of the settlement agreement have not been disclosed. (Vasic et al v. Patent Health, L.L.C. et al, Case No. 13-cv-849, S. D. CA.)
For more information about other class-action lawsuits regarding glucosamine supplements and TINA.org’s coverage of the products, click here.
Why this eyewear company’s advertised “starting” prices may not be 20/20.
MADISON, CONN. Dec. 12, 2024— In a win for consumers, a court has ordered Quincy Bioscience to stop advertising Prevagen using memory-improvement claims. This follows a near-decade-long campaign by the…
What led up to brain supplement’s December to remember.
Jessica Bennett, The Cut
Getting lucky for this cheap may be harder than you think.